{"id":"W2966319593","doi":"10.1136/jnnp-2019-anzan.49","title":"056 Efficacy and safety of the Bruton’s tyrosine kinase inhibitor evobrutinib (M2951) in patients with relapsing multiple sclerosis over 48 weeks: a randomized, placebo-controlled, phase 2 study","year":2019,"lang":"en","type":"article","venue":"Journal of Neurology Neurosurgery & Psychiatry","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Neurological Institute and Hospital; NeuroRx Research (Canada); University of Toronto","funders":"","keywords":"Placebo; Medicine; Clinical endpoint; Internal medicine; Gastroenterology; Randomized controlled trial; Adverse effect; Surgery; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002376185,0.000426481,0.002279905,0.000632975,0.0001156583,0.0000332077,0.0003041263,0.000213796,0.00006607825],"category_scores_gemma":[0.002077456,0.0002577707,0.0004935348,0.0006569979,0.0004461963,0.0002238935,0.0001884717,0.001454245,0.000004827132],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000394602,"about_ca_system_score_gemma":0.002391508,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005484741,"about_ca_topic_score_gemma":0.00002439672,"domain_scores_codex":[0.9939893,0.001652922,0.002087209,0.0005573392,0.001121582,0.0005916144],"domain_scores_gemma":[0.9941649,0.002981176,0.001531424,0.0007456323,0.0003136311,0.0002631728],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5299665,0.003807526,0.4640659,0.00006987176,0.0002121872,0.00009852048,0.0001506224,0.0001134368,0.0008300248,0.000003511444,0.0004774959,0.0002044135],"study_design_scores_gemma":[0.6690819,0.003851265,0.3249123,0.000441605,0.0003597752,0.0002689844,0.00003733784,0.0007638789,0.00006341427,0.000006837411,0.00007050981,0.0001422116],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904616,0.000568856,0.000003308564,0.001801133,0.003164356,0.003922587,0.00001142791,0.00001554488,0.00005114935],"genre_scores_gemma":[0.9981952,0.0001101169,0.0000437287,0.001233829,0.0002498674,0.00002273719,0.000002004465,0.00007946727,0.00006306934],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1391536,"threshold_uncertainty_score":0.9999874,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01080856343688802,"score_gpt":0.2572244751140013,"score_spread":0.2464159116771132,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}